Present and future treatment of asthma in infants and young children

Journal of Allergy and Clinical Immunology

Volumn 104, Issue 4 SUPPL., 1999, Pages

  Martinez, Fernando D ^a,b  

^a UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF ARIZONA   (United States)

Author keywords

Asthma; Inflammation; Inhaled corticosteroids; Lung function; Pediatric; Wheeze

Indexed keywords

BUDESONIDE; CORTICOSTEROID; CROMOGLYCATE DISODIUM; THEOPHYLLINE;

AIRWAY OBSTRUCTION; ASTHMA; BRONCHUS HYPERREACTIVITY; CHILD; CONFERENCE PAPER; DRUG EFFECT; FUTUROLOGY; HUMAN; INFANT; INFLAMMATORY CELL; LUNG FUNCTION; LUNG LAVAGE; MEDIATOR RELEASE; PATHOGENESIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL;

ADMINISTRATION, INHALATION; ADRENAL CORTEX HORMONES; ANTI-ASTHMATIC AGENTS; ASTHMA; CHILD; CLINICAL TRIALS; FORECASTING; HUMANS; INFANT;

EID: 0033495763     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-6749(99)70058-8     Document Type: Article

References (25)

1. Benson V, Marano MA. Current estimates from the National Health Interview Survey, 1995. National Center for Health Statistics. Vital Health Stat 1998:10:77-8.
2. Yunginger JW, Reed CE, O'Connell EJ, Melton LJ, O'Fallon WM, Silverstein MD. A community-based study of the epidemiology of asthma: incidence rates, 1964-1983. Am Rev Respir Dis 1992:146:888-94.
3. Busse WW. Inflammation in asthma: the cornerstone of the disease and target of therapy. J Allergy Clin Immunol 1998;102(suppl):S17-S22.
4. Beasley R, Roche WR, Roberts JA, Holgate ST. Cellular events in the bronchi in mild asthma and bronchial provocation. Am Rev Respir Dis 1989;139:806-17.
5. Awadh N, Muller NL, Park CS, Abboud RT, FitzGerald JM. Airway wall thickness in patients with near fatal asthma and control groups: assessment with high resolution computed tomographic scanning. Thorax 1998;53:248-53.
6. Hogg JC. The pathology of asthma. APMIS 1997;105:735-45.
7. Pare PD, Bai TR, Roberts CR. The structural and functional consequences of chronic allergic inflammation of the airways. In: Chadwick DJ, Cardew G, editors. The rising trends in asthma. Ciba Foundation Symposium 206. West Sussex (England): John Wiley & Sons Ltd; 1997. p. 71-86.
8. Duff AL, Pomeranz ES, Gelber LE, Price GW, Farris H, Hayden FG, et al. Risk factors for acute wheezing in infants and children: viruses, passive smoke, and IgE antibodies to inhalant allergens. Pediatrics 1993;92:535-40.
9. Martinez FD, Helms PJ. Types of asthma and wheezing. Eur Respir J 1998;27(suppl):3s-8s.
10. Martinez FD, Wright AL, Taussig LM, Holberg CJ, Halonen M, Morgan WJ, et al. Asthma and wheezing in the first six years of life. N Engl J Med 1995;332:133-8.
11. Stein RT, Holberg CJ, Morgan WJ, Wright AL, Lombardi E, Taussig L, et al. Peak flow variability, methacholine responsiveness and atopy as markers for detecting different wheezing phenotypes in childhood. Thorax 1997;52:946-52.
12. Pohunek P, Rocke WR, Turzikova J, Kudrmann J, Warner JO. Eosinophilic inflammation in the bronchial mucosa of children with bronchial asthma [abstract]. Eur Respir J 1997;10:160s.
13. Stevenson EC, Turner G, Heaney LG, Schock BC, Taylor R, Gallagher T, et al. Bronchoalveolar lavage findings suggest two different forms of childhood asthma. Clin Exp Allergy 1997;27:1027-35.
14. National Asthma Education and Prevention Program. Expert panel report 2: guidelines for the diagnosis and management of asthma. Bethesda (MD): NIH/National Heart, Lung, and Blood Institute; 1997. Publication no. 97-4051.
15. Bisgaard H, Munck SL, Nielsen JP, Petersen W, Ohlsson SV. Inhaled budesonide for treatment of recurrent wheezing in early childhood. Lancet 1990;336:649-51.
16. Noble V, Ruggins NR, Everard ML, Milner AD. Inhaled budesonide for chronic wheezing under 18 months of age. Arch Dis Child 1992;67:285-8.
17. Reijonen T, Korppi M, Kuikka L, Remes K. Anti-inflammatory therapy reduces wheezing after bronchiolitis. Arch Pediatr Adolesc Med 1996;150:512-7.
18. Kraemer R, Graf Bigler U, Casaulta Aebischer C, Weder M, Birrer P. Clinical and physiological improvement after inhalation of low-dose beclomethasone dipropionate and salbutamol in wheezy infants. Respiration 1997;64:342-9.
19. Richter H, Seddon P. Early nebulized budesonide in the treatment of bronchiolitis and the prevention of postbronchiolitic wheezing. J Pediatr 1998;132:849-53.
20. Wilson N, Sloper K, Silverman M. Effect of continuous treatment with topical corticosteroid on episodic viral wheeze in preschool children. Arch Dis Child 1995;72:317-20.
21. Stick SM, Burton PR, Clough JB, Cox M, LeSouef PN, Sly PD. The effects of inhaled beclomethasone dipropionate on lung function and histamine responsiveness in recurrently wheezy infants. Arch Dis Child 1995;73:327-32.
22. Lorber DB, Kaltenborn W, Burrows B. Responses to isoproterenol in a general population sample. Am Rev Respir Dis 1978;118:855-61.
23. Kelly WJ, Hudson I, Phelan PD, Pain MC, Olinsky A. Atopy in subjects with asthma followed to the age of 28 years. J Allergy Clin Immunol 1990;85:548-57.
24. Oswald H, Phelan PD, Lanigan A, Hibbert M, Carlin JB, Bowes G, et al. Childhood asthma and lung function in mid-adult life. Pediatr Pulmonol 1997;23:14-20.
25. Agertoft L, Pedersen S. Effects of long-term treatment with an inhaled corticosteroid on growth and pulmonary function in asthmatic children. Respir Med 1994;88:373-81.